Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Vinken

Showing results (281-290 of 290) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 290 results.
Biotechnology Advances|April 3, 2025
Taking the 3Rs to a higher level: replacement and reduction of animal testing in life sciences in space researchMathieu Vinken, Daniela Grimm, Sarah Baatout, et al.
Archives of Toxicology|November 17, 2014
Toxicogenomics directory of chemically exposed human hepatocytesMarianna Grinberg, Regina M Stöber, Karolina Edlund, et al.
Archives of Toxicology|January 31, 2022
Correction to: Toxicogenomics directory of chemically exposed human hepatocytesMarianna Grinberg, Regina M Stöber, Karolina Edlund, et al.
ALTEX|March 8, 2022
Application of evidence-based methods to construct mechanism-driven chemical assessment frameworksSebastian Hoffmann, Elisa Aiassa, Michelle Angrish, et al.
Alternatives to Laboratory Animals : ATLA|January 18, 2024
Report of the First ONTOX Stakeholder Network Meeting: Digging Under the Surface of ONTOX Together With the StakeholdersMichael G Diemar, Mathieu Vinken, Marc Teunis, et al.
Archives of Toxicology|October 21, 2017
Adverse outcome pathways: opportunities, limitations and open questionsMarcel Leist, Ahmed Ghallab, Rabea Graepel, et al.
ALTEX|April 17, 2026
Stakeholder input towards further refinement and consolidation of the alternative safety profiling algorithm (ASPA) for next generation risk assessment (NGRA)Mirjam Luijten, Matthias Herzler, Femke Affourtit, et al.
Archives of Toxicology|May 3, 2011
Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010Sarah Adler, David Basketter, Stuart Creton, et al.
ALTEX|January 15, 2022
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design WorkshopLaure-Alix Clerbaux, Núria Amigó, Maria João Amorim, et al.
Archives of Toxicology|August 27, 2013
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADMEPatricio Godoy, Nicola J Hewitt, Ute Albrecht, et al.
Pageof 29

Showing results (281-290 of 290) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 290 results.
Biotechnology Advances|April 3, 2025
Taking the 3Rs to a higher level: replacement and reduction of animal testing in life sciences in space researchMathieu Vinken, Daniela Grimm, Sarah Baatout, et al.
Archives of Toxicology|November 17, 2014
Toxicogenomics directory of chemically exposed human hepatocytesMarianna Grinberg, Regina M Stöber, Karolina Edlund, et al.
Archives of Toxicology|January 31, 2022
Correction to: Toxicogenomics directory of chemically exposed human hepatocytesMarianna Grinberg, Regina M Stöber, Karolina Edlund, et al.
ALTEX|March 8, 2022
Application of evidence-based methods to construct mechanism-driven chemical assessment frameworksSebastian Hoffmann, Elisa Aiassa, Michelle Angrish, et al.
Alternatives to Laboratory Animals : ATLA|January 18, 2024
Report of the First ONTOX Stakeholder Network Meeting: Digging Under the Surface of ONTOX Together With the StakeholdersMichael G Diemar, Mathieu Vinken, Marc Teunis, et al.
Archives of Toxicology|October 21, 2017
Adverse outcome pathways: opportunities, limitations and open questionsMarcel Leist, Ahmed Ghallab, Rabea Graepel, et al.
ALTEX|April 17, 2026
Stakeholder input towards further refinement and consolidation of the alternative safety profiling algorithm (ASPA) for next generation risk assessment (NGRA)Mirjam Luijten, Matthias Herzler, Femke Affourtit, et al.
Archives of Toxicology|May 3, 2011
Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010Sarah Adler, David Basketter, Stuart Creton, et al.
ALTEX|January 15, 2022
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design WorkshopLaure-Alix Clerbaux, Núria Amigó, Maria João Amorim, et al.
Archives of Toxicology|August 27, 2013
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADMEPatricio Godoy, Nicola J Hewitt, Ute Albrecht, et al.
Pageof 29